Position
Fidelity in Stoke Therapeutics, Inc.
Back to the book · All holders of STOK
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $850.1K$32.56 → $32.72
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 5.6M | $177.8M | — | — | — | 0.0% |
| Q1 2026 | 5.38M | $175.3M | $32.56 | $4.41M | −$6.9M | 0.0% |
| Q2 2026 | 5.31M | $173.8M | $32.72 | $850.1K | −$2.3M | 0.0% |